BioHarvest Sciences (NASDAQ:BHST) & Kimberly-Clark (NASDAQ:KMB) Critical Review

Kimberly-Clark (NASDAQ:KMB) and BioHarvest Sciences (NASDAQ:BHST) are both consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Institutional & Insider Ownership

76.3% of Kimberly-Clark shares are owned by institutional investors. 0.7% of Kimberly-Clark shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Kimberly-Clark has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Kimberly-Clark and BioHarvest Sciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kimberly-Clark	1	11	4	1	2.29
BioHarvest Sciences	1	0	2	0	2.33

Kimberly-Clark currently has a consensus price target of $116.50, suggesting a potential upside of 11.94%. BioHarvest Sciences has a consensus price target of $6.50, suggesting a potential upside of 282.35%. Given BioHarvest Sciences’ stronger consensus rating and higher probable upside, analysts plainly believe BioHarvest Sciences is more favorable than Kimberly-Clark.

Profitability

This table compares Kimberly-Clark and BioHarvest Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kimberly-Clark	11.79%	143.92%	14.21%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

Earnings and Valuation

This table compares Kimberly-Clark and BioHarvest Sciences”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kimberly-Clark	$16.58 billion	2.09	$2.02 billion	$5.88	17.70
BioHarvest Sciences	$34.51 million	0.97	-$11.14 million	($0.52)	-3.27

Kimberly-Clark has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Kimberly-Clark, indicating that it is currently the more affordable of the two stocks.

Summary

Kimberly-Clark beats BioHarvest Sciences on 12 of the 15 factors compared between the two stocks.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company’s K-C Professional segment offers wipers, tissues, towels, apparel, personal protective equipment, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. It also sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to distributors, manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

About BioHarvest Sciences

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.